Achilles Therapeutics PLC SITC and Corporate Update Call Transcript
Welcome to the Achilles Therapeutics SITC corporate update call. My name is Deborah and I will be your operator for today's call. (Operator Instructions). Please note that this conference is being recorded. I will now turn the call over to Lee Stern, Vice President Investor Relations and External Communications at Achilles. Lee, you may begin.
Thank you, Deborah. We are glad you joined us for our review of today's SITC presentations and a brief corporate update. Prior to this call we issued a press release and posted a slide presentation that can be found on our website at www.achillestx.com. We will refer to this during our prepared remarks.
On today's call we have the pleasure of being joined by Dr. Samra Turajlic of the Royal Marsden's NHS Foundation Trust. Dr. Turajlic is the Chief Investigator of our THETIS clinical trial. In addition from Achilles, I am joined by Iraj Ali, our Chief Executive Officer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |